marketshare

  The Global Laparoscopic and Open Hernia Mesh Repair Surgery Market report, published by Emergen Research, is a detail-oriented compilation of the crucial aspects of the Laparoscopic and Open Hernia Mesh Repair Surgery Market , including the key players’ product offerings, the wide application range of these products, the major market segments, leading market contenders, their company profiles, pricing strategies, production capacities, revenue generation schemes, technological advancements, and many others. The primary addressees of this report include some of the globally renowned venture capitalists. The global laparoscopic and open hernia mesh repair surgery market size was USD 3.29 Billion in 2022 and is expected to register a revenue CAGR of 2.2% during the forecast period.  The laparoscopic and open hernia mesh repair surgery market is a vital segment of the healthcare industry, addressing the treatment of hernias, which occur when an organ or tissue protrudes through...

  Surgical robots market size was worth USD 3.60 billion in 2021, with a 19.3% CAGR. Robotic surgeries, medical devices, and federal device identifications drive market expansion. Robotic surgeries improve dexterity, eyesight, hand-eye coordination, and posture. These devices enable challenging procedures. Medical device innovation and healthcare industry cooperation may improve market revenue. Smith & Nephew announced its Real Intellectual Ability suite of supporting technology solutions in India on July 13, 2021, comprising its next-generation robotics platform, CORI Surgical System. Investing on user-friendly and affordable surgical roots and hospital infrastructure is growing surgical robot demand. Neocis, a dental implant surgical robot maker, raised USD 40 Billion from California-based Intuitive Ventures on October 28, 2022. Yomi, the FDA-approved company's first surgical instrument, helps dentists plan and perform implant surgery. Robots that lessen discomfort, incisions...

  The global breast biopsy market size reached USD 2.96 Billion in 2022 and is expected to register a revenue CAGR of 5.7% during the forecast period, according to the latest analysis by Emergen Research. Growing developments in molecular imaging-related technologies is a key factor driving revenue growth of the market. One of the main factors driving market revenue growth is the expansion of research & development into the creation of breast biopsy platforms to treat chronic breast illnesses. The development of novel technologies is made possible by the rising research activities carried out by numerous institutions around the world. These technologies effectiveness makes it easier for them to enter the market. The market revenue growth is significantly influenced by the rising incidence of breast cancer. The  Breast Biopsy Market Market  report also offers an in-depth analysis of the market players along with their business overview, product portfolio, technological...